Explore European Union Legislation by Asking a Legal Question
assisted-checkbox
filter-instruction-1
positive-filters
negative-filters
act-filter tabs-all
parameters-title
query
assisted-checkbox: ✅
result-title
total 6
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_I CELEX: 31997R0467 Additional INNs to receive duty-free treatment
CN code
CAS RN
Name
2844 40 30
113716-48-6
Iolopride (123 I)
142481-95-6
Technetium (99m Tc) furifosmin
2846 90 00
131069-91-5
Gadoversetamide
135326-11-3
Gadoxetic acid
138721-73-0
Sprodiamide
2914 40 90
20098-14-0
Idramantone
2916 39 00
71109-09-6
Vedaprofen
2918 30 00
22161-81-5
Dexketoprofen
112665-43-7
Seratrodast
2918 90 90
139403-31-9
Pimilprost
2921 49 90
136236-51-6
Rasagiline
2922 49 70
6582-31-6
Dapabutan
2923 90 00
1794-75-8
Laurcetium bromide
2924 10 00
1675-66-7
Adelmidrol
62304-98-7
Thymalfasin
132787-19-0
Tradecamide
129009-83-2
Versetamide
2924 29 90
147362-57-0
Loviride
94497-51-5
Tamibarotene
2925 19 80
144849-63-8
Bisnafide
2925 20 00
137159-92-3
Aptiganel
2926 90 80
137109-71-8
Balazipone
147076-36-6
Laflunimus
2928 00 90
141579-54-6
Fenleuton
2930 90 16
87573-01-1
Salnacedin
2930 90 70
90357-06-5
Bicalutamide
112573-72-5
Dexecadotril
107023-41-6
Pobilukast
81110-73-8
Racecadotril
2931 00 50
132236-18-1
Zifrosilone
2931 00 80
114084-78-5
Ibandronic acid
124351-85-5
Incadronic acid
63132-39-8
Olpadronic acid
2932 99 70
105674-77-9
Lanproston
2932 99 90 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_I CELEX: 31997R0467 123407-36-3
Arteflene
132017-01-7
Bervastatin
110816-79-0
Cromoglicate lisetil
149494-37-1
Ebalzotan
151581-24-7
Iralukast
113806-05-6
Olopatadine
139110-80-8
Zanamivir
2933 29 90
158682-68-9
Elisartan
116684-92-5
Galdansetron
89371-44-8
Imidaprilat
138402-11-6
Irbesartan
118072-93-8
Zoledronic acid
2933 39 95
119257-34-0
Besipirdine
118248-91-2
Fodipir
155415-08-0
Inogatran
121750-57-0
Itameline
144412-49-7
Lamifiban
155319-91-8
Mangafodipir
150443-71-3
Nicanartine
29876-14-0
Nicotredole
144035-83-6
Piclamilast
137795-35-8
Spiroglumide
147025-53-4
Talsaclidine
149488-17-5
Trovirdine
2933 40 10
127294-70-6
Balofloxacin
143383-65-7
Premafloxacin
143224-34-4
Telinavir
2933 40 90
96946-42-8
Cisatracurium besilate
158966-92-8
Montelukast
136668-42-3
Quiflapon
2933 59 70
127266-56-2
Adatanserin
106941-25-7
Adefovir
113852-37-2
Cidofovir
150756-35-7
Efletirizine
119687-33-1
Iganidipine
127759-89-1
Lobucavir
140945-32-0
Mapinastine
134208-17-6
Mazapertine
96604-21-6
Ocinaplon
148504-51-2
Ripisartan
115762-17-9
Ruzadolane
118420-47-6
Tagorizine
137234-62-9
Voriconazole
151319-34-5
Zaleplon
2933 79 00
148396-36-5
Fradafiban
74436-00-3
Geclosporin |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_I CELEX: 31997R0467 143943-73-1
Lirequinil
106730-54-5
Olprinone
135548-15-1
Oxeclosporin
145733-36-4
Tasosartan
143343-83-3
Toborinone
2933 90 95
137882-98-5
Abitesartan
114607-46-4
Acitazanolast
120511-73-1
Anastrozole
134523-00-5
Atorvastatin
128270-60-0
Bivalirudin
139481-59-7
Candesartan
54278-85-2
Candocuronium iodide
105806-65-3
Efegatran
62568-57-4
Emideltide
120081-14-3
Goralatide
142880-36-2
Ilornastat
62732-44-9
Ipidacrine
116287-14-0
Lanperisone
112809-51-5
Letrozole
116644-53-2
Mibefradil
136122-46-8
Mipitroban
144702-17-0
Pomisartan
132036-88-5
Ramosetron
106308-44-5
Rufinamide
144701-48-4
Telmisartan
147059-72-1
Trovafloxacin
2934 10 00
149079-51-6
Cartasteine
128312-51-6
Cinalukast
51287-57-1
Denotivir
101001-34-7
Pamicogrel
136433-51-7
Tazofelone
138742-43-5
Zankiren
2934 20 90
144665-07-6
Lubeluzole
150915-41-6
Perospirone
146939-27-7
Ziprasidone
2934 90 60
130370-60-4
Batimastat
133040-01-4
Eprosartan
135202-79-8
Ilonidap
114686-12-3
Imitrodast
132418-36-1
Rocepafant
132418-35-0
Setipafant
2934 90 70
125533-88-2
Mofarotene
127045-41-4
Pazufloxacin
2934 90 80
118292-40-3
Tazarotene
2934 90 98
151356-08-0
Afovirsen
138298-79-0
Alnespirone |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_I CELEX: 31997R0467 152317-89-0
Alniditan
153420-96-3
Atibeprone
143393-27-5
Azalanstat
149908-53-2
Azimilide
150490-85-0
Berupipam
154361-50-9
Capecitabine
133099-04-4
Darifenacin
137500-42-6
Darsidomine
114030-44-3
Dexpemedolac
115464-77-2
Elopiprazole
141790-23-0
Fozivudine tidoxil
122254-45-9
Glenvastatin
143443-90-7
Ifetroban
82857-82-7
Ilepcimide
104454-71-9
Ipenoxazone
118288-08-7
Lafutidine
138068-37-8
Lepirudin
78994-23-7
Levormeloxifene
116476-16-5
Levosemotiadil
148152-63-0
Napitane
84558-93-0
Netivudine
147432-77-7
Ontazolast
139225-22-2
Panamesine
103255-66-9
Pazinaclone
123447-62-1
Prulifloxacin
131986-45-3
Xanomeline
145781-32-4
Zolasartan
2935 00 90
147536-97-8
Bosentan
136817-59-9
Delavirdine
119905-05-4
Delequamine
112966-96-8
Domitroban
125279-79-0
Ersentilide
139133-26-9
Lexipafant
154397-77-0
Napsagatran
139133-27-0
Nupafant
116649-85-5
Ramatroban
133276-80-9
Samixogrel
146623-69-0
Saprisartan
149556-49-0
Susalimod
144494-65-5
Tirofiban
139308-65-9
Tolafentrine
107753-78-6
Zafirlukast
2936 29 90
131875-08-6
Lexacalcitol
2937 10 10
9002-68-0
Follitropin alfa
152923-57-4
Lutropin alfa
2937 22 00
103466-73-5
Icometasone enbutate
2937 29 90
144459-70-1 |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_I CELEX: 31997R0467 Rofleponide
2937 99 00
124478-60-0
Aglepristone
140703-51-1
Examorelin
133107-64-9
Insulin lispro
144743-92-0
Teverelix
2939 50 90
151581-23-6
Apaxifylline
132210-43-6
Cipamfylline
100324-81-0
Lisofylline
98833-92-2
Stacofylline
2939 90 90
135905-89-4
Mirisetron
117086-68-7
Ricasetron
25775-90-0
Zucapsaicin
2940 00 90
133692-55-4
Seprilose
2941 90 00
127785-64-2
Basifungin
116853-25-9
Cefluprenam
122841-10-5
Cefoselis
156131-91-8
Dimadectin
123997-26-2
Eprinomectin
149951-16-6
Lenapenem
108852-90-0
Nemorubicin
159445-62-2
Orientiparcin
156769-21-0
Sanfetrinem
3001 90 99
120993-53-5
Desirudin
3002 10 91
143653-53-6
Abciximab
156227-98-4
Afelimomab
151763-64-3
Capromab
152923-56-3
Dacliximab
145832-33-3
Detumomab
142864-19-5
Enlimomab
152981-31-2
Inolimomab
150631-27-9
Nacolomab tafenatox
159445-64-4
Odulimomab
147191-91-1
Priliximab
153101-26-9
Regavirumab
148189-70-2
Votumumab
3002 10 95
143090-92-0
Anakinra
143631-61-2
Atexakin alfa
148637-05-2
Cilmostim
154725-65-2
Epoetin epsilon
148363-16-0
Epoetin omega
102786-52-7
Eptacog alfa (activated)
156679-34-4
Lenercept
124146-64-1
Mobenakin
0-00-0
Moroctocog alfa
148641-02-5
Muplestim |
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical article annex_I CELEX: 31997R0467 139076-62-3
Octocog alfa
3003 39 00
0-00-0
Plusonermin
3003 90 90
0-00-0
Fuladectin
3507 90 90
143831-71-4
Dornase alfa
154248-97-2
Imiglucerase
149394-67-2
Ledimase
156616-23-8
Monteplase
159445-63-3
Nateplase
155773-57-2
Pegorgotein
3911 90 19
95522-45-5
Colestilan
31512-74-0
Polixetonium chloride
3913 90 80
39464-87-4
Betasizofiran
0-00-0
Certoparin sodium
0-00-0
Minolteparin sodium |